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Background: Neurodegenerative diseases are characterized by key features such as loss
of neurons, astrocytosis, and microglial activation/proliferation. These changes cause dif-
ferences in the density of cell types between control and disease subjects, confounding
results from gene expression studies. Chromosome X (ChrX) is known to be specifically
important in the brain. We hypothesized the existence of a chromosomal signature of gene
expression associated with the X-chromosome for neurological conditions not normally
associated with that chromosome. The hypothesis was investigated using publicly avail-
able microarray datasets from studies on Parkinson’s disease, Alzheimer’s disease, and
Huntington’s disease. Data were analyzed using Chromowave, an analytical tool for detect-
ing spatially extended expression changes along chromosomes. To examine associations
with neuronal density and astrocytosis, the expression of cell specific reporter genes was
extracted. The association between these genes and the expression patterns extracted
by Chromowave was then analyzed. Further analyses of the X:Autosome ratios for laser
dissected neurons, microglia cultures and whole tissue were performed to detect cell spe-
cific differences. Results: We observed an extended pattern of low expression of ChrX
consistent in all the neurodegenerative disease brain datasets.There was a strong correla-
tion between mean ChrX expression and the pattern extracted from the autosomal genes
representing neurons, but not with mean autosomal expression. No chromosomal patterns
associated with the neuron specific genes were found on other chromosomes. The chro-
mosomal expression pattern was not present in datasets from blood cells.The X:Autosome
expression ratio was also higher in neuronal cells than in tissues with a mix of cell types.
Conclusions:The results suggest that neurological disorders show as a reduction in mean
expression of many genes along ChrX.The most likely explanation for this finding relates to
the documented general up-regulation of ChrX in brain tissue which, this work suggests,
occurs primarily in neurons. If validated, this cell specific ChrX expression warrants further
research as understanding the biological reasons and mechanisms for this expression, may
help to elucidate a connection with the development of neurodegenerative disorders.
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INTRODUCTION
In recent years several studies have used expression microarrays
to investigate the molecular signature of neurodegenerative dis-
eases and identify candidate genes relevant to their pathogenesis
(Blalock et al., 2004; Hodges et al., 2006; Moran et al., 2006; Papa-
petropoulos et al., 2006; Scherzer et al., 2007). Irrespective of the
condition, the affected brains show a progressive and irreversible
nerve cell loss that increases with the severity of the disease
(Hedreen and Folstein, 1995; Gómez-Isla et al., 1997; Bossers et al.,
Abbreviations: AD, Alzheimer’s disease; ChrX, chromosome X; GEO, gene expres-
sion omnibus; HD, Huntington’s disease; PD, Parkinson’s disease; SVD, singular
value decomposition.
2009). Brains with neurodegenerative diseases also show reactive
astrocytosis and microglial activation. Such changes result in an
altered ratio of neuronal and non-neuronal mRNA and represent
an important variable in gene expression studies (Oldham et al.,
2008; Clarke et al., 2010).
The X-chromosome (ChrX) contains a large number of genes
that are essential for brain development and function (Laumon-
nier et al., 2007). Several brain disorders are also associated
with mutations of genes on ChrX (Oostra and Willemsen, 2002;
Chadwick and Wade, 2007; Zanni and Bertini, 2011). In mam-
malian brains the global expression of ChrX is higher than in
other tissues (Nguyen and Disteche, 2006b). Higher X-expression
in brain tissue has been linked to “X dosage compensation,” a
mechanism that matches the expression of X-linked genes with
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the expression of genes on autosomal chromosomes in organisms
where sex determination depends on highly dimorphic sex chro-
mosomes (Nguyen and Disteche, 2006a; Straub and Becker, 2007;
Deng et al., 2011; Kharchenko et al., 2011). Whether all brain cells
or only certain types of cells exhibit this increased expression is
unknown. However it is known that varying density of different
cell types in brain will impact measured expression values (Clarke
et al., 2010).
Gene expression studies are an important source of data for
investigating neurodegenerative disorders, however lists of differ-
entially expressed genes often do little to improve understanding
of disease mechanisms or of the underlying biology. Approaches
which address microarray data analysis by looking at networks
(Mitchell and Mirnics, 2012) or other system level analysis can pro-
vide a more interpretable and hence useful viewpoint (Langfelder
and Horvath, 2008; Mar et al., 2011). So far, however, a systemic
and important factor, spatial location, has been generally over-
looked from microarray analytics (Hurst et al., 2004; Turkheimer
et al., 2006). Spatial location can be important in biological systems
regulated by chromatin (Anderson et al., 2008), or for variations
in copy number (Turkheimer et al., 2006) and so is likely to be use-
ful when dealing with high X-expression in the brain.Chromowave
(Turkheimer et al., 2006; Anderson et al., 2008), is an analytical tool
designed to analyze chromosomal patterns of expression variation
from adjacent genes to include spatial factors into the modeling
process.
In the present study, we used datasets obtained from the
brains of subjects with Parkinson’s disease (PD; Moran et al.,
2006; Papapetropoulos et al., 2006; Durrenberger et al., 2012),
Alzheimer’s disease (AD; Blalock et al., 2004) and Huntington’s
disease (HD; Hodges et al., 2006) and age matched controls to
test whether similar spatial expression patterns occur in differ-
ent neurological conditions. Further it was hypothesized that the
patterns would mirror the changes in neuronal densities and that
the patterns would arise specifically on ChrX. We used a novel
approach Chromowave to look at the spatial expression patterns
that may indicate neuronal loss. Major patterns of ChrX expression
were extracted using Chromowave. These datasets used a range of
different microarray platforms and pre-processing methods. Fur-
ther expression datasets from blood cells in PD and HD were
used as negative controls. The case loadings from ChrX patterns
were then compared with the primary expression pattern from
a series of neuronal reference genes on the autosomes as a way
to infer their relationship with varying densities of neurons in
the samples. Furthermore, mean ratios of X:Autosome expression
were obtained from control subjects and laser dissected neurons
(Dunckley et al., 2006; Zheng et al., 2010) to test whether neurons
express ChrX at different levels to samples containing a mix of
cell types. Primary cell culture samples of fetal microglia were also
obtained from a public database to test the alternative hypothesis
that imbalances in the X:Autosome ratio was due to microglial
proliferation.
MATERIALS AND METHODS
MICROARRAY DATA
Data from whole tissues were obtained from online databases
(mostly GEO except for the HD caudate samples from Array
express) from different diseases and platforms. These datasets are
summarized in Table 1, with clinical details available in the original
references. Data was also obtained from blood samples for PD and
HD. Blood samples were used to determine whether findings were
tissue specific. These datasets were further supplemented by two
publicly available datasets of laser microscopy dissected neurons.
Only the control samples from these datasets were used and only
those genes showing significant detection values were included.
Clinical details of whole tissue samples are found in Table 2 with
further details available in the original publications. Data from
human fetal microglia samples from four brains were also acquired
from the GEO. Microglia samples were acquired at a range of time
points, and here only those from the first time point (1 h) were
used. This was because the X:Autosome ratio was time dependent
with these having the highest ratio.
Neuronal and astrocytic reporter genes were selected from a
transcriptome database (Cahoy et al., 2008). Only genes with fold
change >20 in the database were included, with those on ChrX
excluded a priori to avoid biasing for that chromosome. All probes
representing any of these genes in the dataset were included.
MICROARRAY DATA PRE-PROCESSING
The Data from the lateral and medial substantia nigra were already
normalized and log2 transformed, as described in the original
study (Moran et al., 2006). For the Illumina dataset, normaliza-
tion was conducted using the Rosetta error models available in
the Rosetta Resolver®system (Rosetta Biosoftware, Seattle, WA,
USA; Weng et al., 2006). Values were then log2 transformed. Data
from other datasets were normalized by dividing intensities by
the median value of those genes presenting with positive detec-
tion (present call P in Affymetrix notation). Values were then log2
transformed.
CHROMOWAVE ANALYSIS OF GENE EXPRESSION
Data were analyzed with Chromowave (Turkheimer et al., 2006;
Anderson et al., 2008), written in MATLAB (The Mathworks, Inc.,
Natick, MA, USA). Chromowave first mapped the probes from
the datasets to their corresponding chromosomal location and
then applied the wavelet transform to their spatial distribution,
converting the expression values into wavelet coefficients. Each
wavelet coefficient represents the average value of adjacent probes
at different length scales (2-4-8-16. . . adjacent probes depend-
ing on the scale) in each specific location on a chromosome and
can be manipulated using standard statistical methodologies to
extract coherent spatial patterns in the data (Turkheimer et al.,
2006).
The wavelet transform represents the data in a different form
which emphasizes the similarity in expression between groups of
adjacent probes. Transforming the data into wavelet space ampli-
fies groups of adjacent probes with similar expression behavior
so that they have a larger effect on the analysis than individ-
ual probes when analyzed independently. For example if a large
group of adjacent probes were more highly expressed in patients
than in controls this may result in a significant difference in the
wavelet representation, even though none of the probes would
individually demonstrate a significant signal. The wavelet method-
ology analyzes the data through a range of different scales (from
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Table 1 | Datasets.
Disease Region Reference Accession Platform Subjects
PD Lateral nigra Moran et al. (2006) GSE8397 Affymetrix HG-U133A B 6 controls, 13 PD*
PD Medial nigra Moran et al. (2006) GSE8397 Affymetrix HG-U133A B 5 controls, 13 PD#
PD Substantia nigra Papapetropoulos et al. (2006) GSE7621 Affymetrix HG-U133 plus 2 9 controls, 16 PD
PD Substantia nigra Durrenberger et al. (2012) GSE26927 Illumina humanRef8 v2.0 7 controls, 12 PD
AD Hippocampus Blalock et al. (2004) GSE1297 Affymetrix HGU133A 8 controls, 18 AD
HD Caudate Hodges et al. (2006) E-AFMX-6 Affymetrix HG-U133A B 11 controls, 17 HD
HD blood Hodges et al. (2006) GSE1751 Affymetrix HGU133A 12 controls, 14 HD
PD blood Scherzer et al. (2007) GSE6613 Affymetrix HGU133A 21 controls, 50 PD
controls Substantia nigra neurons Zheng et al. (2010) GSE20141 Affymetrix HG-U133 plus 2 8 controls
controls Entorhinal cortex neurons Dunckley et al. (2006) GSE4757 Affymetrix HG-U133 plus 2 10 controls
controls Human fetal microglia Rock et al. (2005) GSE1432 Affymetrix HGU133A 4 controls
*One control and one patient were removed due to multiple sclerosis and AD respectively.
#One control was removed due to multiple sclerosis. Two patients were removed one due to AD the other was a juvenile genetic case.
Table 2 | Clinical details for each dataset obtained from original publications.
Dataset Age (yrs)
controls
Age (yrs)
patients
Duration of illness PMI controls PMI patients Tissue pH
(controls)
Tissue pH
(patients)
PD medial nigra 69.3±4.9 81.4±1.6 13.2±2.5 15.6±5 12.9±1.9 6.5±0.13 6.3±0.23
PD lateral 65.6±5.2 82.3±1.7 13.3±1.4 12±4.6 14.6±3.1 6.4±0.4 6.45±0.08
Whole Nigra 78.26±11.4 75±7.4 12.9±6.9 7.8±4.1 6.8±4.8 6.3±0.3 6.2±0.2
Illumina 64.5±5.8 81.5±1.3 13±1.9 27.94±4.84 12.2±1.91 NA 6.82±0.2
AD 85.3±2.7 85.7±2.6 NA 2.6±0.2 3.2±0.4 NA NA
HD 53±20 53±16 NA NA NA NA NA
adjacent pairs of probes to whole chromosomes) and is there-
fore suitable for detecting relatively small events incorporating a
handful of probes to larger events up to whole chromosomes or
genomes. The wavelet transform is widely used in many fields,
including gene analysis (Lio, 2003). Chromowave has been val-
idated in previous publications for the detection of expression
differences caused by copy number variation (Turkheimer et al.,
2006) and disruption caused by Huntington’s disease (Anderson
et al., 2008).
In Chromowave, statistical analysis is performed on the wavelet
coefficients by application of the singular value decomposition
(SVD), a proven technique for the reduction of data dimensional-
ity also used in microarray data analysis (Alter et al., 2000). SVD
factorizes the data into a set of expression patterns (equivalent
to principle components) and case loadings. Case loadings are
a series of values each representing the strength of the detected
spatial pattern for each individual subject. As each subject is rep-
resented by one case loading, these values can be analyzed using
standard statistical techniques, such as regression models and t -
tests. Performing the analysis in wavelet space instead of on the
probe sets, identifies the major spatial patterns of gene expression
(Turkheimer et al., 2006), rather than the functional expression
patterns of individual probes.
In this work, Chromowave was applied to X-linked probes
for each dataset and the largest component from chromosome
X was extracted. Values which were inferred to represent noise
(Turkheimer et al., 2006) were removed and the remaining coef-
ficients were transformed back into differential expression val-
ues and plotted against their genomic location. The resulting
profiles are therefore smoothed representations of the spatial
variation in expression plotted against their chromosomal posi-
tion. The case loadings for each subject associated with the X
related patterns were correlated with the expression of a series of
“reporter genes” indicative of neuronal, astrocytic and microglial
mRNA expression. Other disease related variables were also
investigated.
EXTRACTION OF PATTERNS FROM REPORTER GENES
Genes representative of neurons and astrocytes were selected from
a transcriptome database (Cahoy et al., 2008). Only genes with fold
change >20 in the database publication were chosen, except those
on ChrX which were excluded a priori to avoid spurious associa-
tion. The expression of all the probes representing these genes in
each dataset were extracted, logged, and analyzed using SVD. This
allowed for the extraction of the primary expression pattern from
these genes. This is a more robust method to summarize the data
than a simple average, though averages were subsequently used
to verify the direction of association. The correlation coefficients
between the primary patterns extracted here and the case loadings
obtained from chromosomal expression were then calculated.
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FIGURE 1 | Primary expression pattern from ChrX extracted via
Chromowave from all brain samples.The case loadings for all patterns
correlated significantly with the activity of the “neuronal reporter genes”
used. Negative differential expression values indicate low Chromosome
X-expression associated with reduced neuronal reporter gene expression,
positive values indicated increased expression. Reduced expression is also
associated with neurological disease. The patterns demonstrate reduced gene
expression over the majority of ChrX with the exception of the p-end.
STATISTICAL ANALYSIS
Statistical analysis was performed in MATLAB R2011a (The
Mathworks, Inc., Natick, MA, USA), using parametric methods
(Pearson correlation coefficients, Student t -tests, both two-tailed).
RESULTS
X-EXPRESSION NEURODEGENERATION AND AGING
All datasets from whole tissue brain samples demonstrated sim-
ilar, patterns of ChrX expression that extended through the
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Table 3 | Correlation of X-pattern from whole tissue with neuronal
reporter genes.
Disease Tissue region Platform Correlation
PD Lateral nigra Affymetrix HGU133A and B r =0.82,
p=0.0006
PD Medial nigra Affymetrix HGU133A and B r =0.75,
p=0.0002
PD Substantia nigra Affymetrix HGU133 plus 2 r =0.89,
p=3×10−9
PD Substantia nigra Illumina HumanRef8 v2 r =0.86,
p=1×10−6
AD Hippocampus Affymetrix HGU133A r =0.8,
p=1×10−6
HD Caudate Affymetrix HGU133A and B r =0.92,
p=2×10−12
whole chromosome with the exception of the telomeric p-region
(see Figure 1). Patterns were reproducible despite the variety of
platforms, protocols, and normalization methods used. All case
loadings from ChrX correlated with the patterns of expression
extracted from the autosomal genes representing neuronal den-
sity (Table 3) with lower expression of those X-genes in the profile
associated with lower expression of the neuronal reporter genes. In
a few datasets significant correlations were observed with the astro-
cytic reporter gene-set (Table 4) but in these instances the variance
explained was lower than the one explained by the neuronal gene-
set. Stepwise multiple regression of these datasets indicated that
astrocytic reporter genes did not add significant extra information
to that provided by the neuronal reporter genes.
In PD brain tissue, ChrX case loadings differed between
patients and controls if female subjects were removed (p= 0.047,
0.00004, 0.007, and 0.002 respectively). In the HD caudate the
case loadings differed significantly between patients and controls
(p= 6× 10−5). Removing gender did not produce significance in
other datasets and no comparisons of genders were made in any
dataset (due to small numbers of subjects). Patterns derived from
brain tissues were not reproduced in datasets derived from blood
tissues (Figure 2).
Loss of neurons is also generally associated with natural aging
and hence the case loadings from the largest control group (cau-
date samples) were correlated against age. The results showed a
trend correlation (r= 0.79, p= 0.08) of decreasing X-expression
(of the genes in the pattern) with age. In the patient groups
there was significant association of case loadings with duration
of illness in the Illumina dataset (r = 0.6, p= 0.04) but not in
the medial nigra (r = 0.34 p= 0.3) or the lateral nigra (r = 0.22
p= 0.6) datasets. No significant associations were found in these
datasets between the case loadings and post-mortem interval, pH
or brain weight.
AUTOSOMES AND NEURODEGENERATION
Application of Chromowave to the autosomal probes in the
datasets above retrieved patterns that were associated with neu-
rodegeneration in AD (r = 0.7, p= 0.00001) and HD (r = 0.6,
p= 0.0006), but not in the PD datasets, however these patterns
Table 4 | Correlation of X-pattern from whole tissue with astrocytic
reporter genes.
Disease Tissue region Platform Correlation
PD Lateral nigra Affymetrix HGU133A and B r =0.04,
p=0.9
PD Medial nigra Affymetrix HGU133A and B r=0.3,
p=0.3
PD Substantia nigra Affymetrix HGU133 plus 2 r=0.3,
p=0.1
PD Substantia nigra Illumina HumanRef8 v2 r =0.0004,
p>0.99
AD Hippocampus Affymetrix HGU133A r =0.48,
p=0.01
HD Caudate Affymetrix HGU133A and B r=0.67,
p=0.0001
varied widely across datasets. Results such as these are likely to
represent disease specific findings or false positives, and as such
are outside the scope of this paper.
CHRX:AUTOSOME RATIO FOR LASER MICRO-DISSECTED NEURONS
ANDWHOLE TISSUE
To investigate whether neurons have higher mean expression of
ChrX than other brain cell types, publicly available neuronal
data acquired through laser dissection microscopy was used. The
X:Autosome ratio for each laser dissected sample was compared
with the ratio for control subjects for each whole tissue dataset.
The two sets of dissected neurons had higher mean X:Autosome
ratios than the control cases from the whole tissue samples. The
p-values for each comparison can be found in Table 5.
CHRX:AUTOSOME RATIO FOR MICROGLIA ANDWHOLE TISSUE
To test the alternative hypothesis that it is the X:Autosome ratio
in microglia driving the chromosome X results, four publicly
available microglial control subjects were used. The X:Autosome
ratio for these four samples was 1± 0.01, the expected ratio for
non-brain tissue. The X:Autosome ratio for these four samples
was significantly lower than controls from all datasets of laser dis-
sected neurons and whole tissue samples (except the substantia
nigra samples measured using the Illumina array). The p-values
for each comparison are included in Table 6.
DISCUSSION
The first set of our results demonstrated a reduced chromosome
X-expression in brain (with the exclusion of the far telomeric Xp
region) associated with neurodegenerative disorders. The pattern
of low expression was strongly associated with lower expres-
sion of the neuronal reporter genes in all brain datasets. There
was a significant association with the astrocytic reporter genes
in two datasets (AD caudate and HD hippocampus) which is
likely due to the correlation between astrocytosis and loss of
neurons. The association was less than that with the neuronal
reporter genes and application of stepwise regression indicated
that the association did not explain significant extra variance.
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FIGURE 2 | Primary expression pattern from PD blood (left) and HD blood (right) datasets. Profiles were not associated with neuronal reporter genes and
are visually different from each other and those obtained from brain tissue.
Table 5 | Higher X:Autosome ratio for laser dissected neurons than whole tissues.
Neuron sample location Array type Whole tissue location Array type p-value
Substantia nigra Affymetrix HGU133 plus 2 Substantia nigra Affymetrix HGU133 plus 2 p=5×10−5
Substantia nigra Affymetrix HGU133 plus 2 Medial substantia nigra Affymetrix HGU133A and B p=7×10−5
Substantia nigra Affymetrix HGU133 plus 2 Lateral substantia nigra Affymetrix HGU133A and B p=7×10−5
Substantia nigra Affymetrix HGU133 plus 2 Substantia nigra Illumina HumanRef8 v2 p=4×10−5
Substantia nigra Affymetrix HGU133 plus 2 Hippocampus Affymetrix HGU133A p=1×10−4
Substantia nigra Affymetrix HGU133 plus 2 Caudate Affymetrix HGU133A and B p=6×10−5
Entorhinal cortex Affymetrix HGU133 plus 2 Substantia nigra Affymetrix HGU133 plus 2 p=5×10−3
Entorhinal cortex Affymetrix HGU133 plus 2 Medial substantia nigra Affymetrix HGU133A and B p=4×10−3
Entorhinal cortex Affymetrix HGU133 plus 2 Lateral substantia nigra Affymetrix HGU133A and B p=7×10−3
Entorhinal cortex Affymetrix HGU133 plus 2 Substantia nigra Illumina HumanRef8 v2 p=3×10−5
Entorhinal cortex Affymetrix HGU133 plus 2 Hippocampus Affymetrix HGU133A p=6×10−2
Entorhinal cortex Affymetrix HGU133 plus 2 Caudate Affymetrix HGU133A and B p=5×10−5
Table 6 | Lower X:Autosome ratio for microglia than neurons and
whole tissues.
Sample location Array type p-value
Laser dissected neurons
(substantia nigra)
Affymetrix HGU133 plus 2 4×10−5
Laser dissected neurons
(Entorhinal cortex)
Affymetrix HGU133 plus 2 2×10−5
Lateral substantia nigra Affymetrix HGU133A and B 6×10−3
Medial substantia nigra Affymetrix HGU133A and B 2×10−3
Substantia nigra Affymetrix HGU133 plus 2 5×10−3
Substantia nigra Illumina HumanRef8 v2 0.2
Hippocampus Affymetrix HGU133A 6×10−7
Caudate Affymetrix HGU133A and B 4×10−7
Neuronal reporter genes were not associated with autosomal pat-
terns or mean autosomal expression. To test further whether
reduction in expression in neurodegeneration was due to neu-
ronal loss in the samples, the available mRNA data on laser dis-
sected neurons were analyzed and we showed that laser dissected
neurons had higher X:Autosome expression ratios than whole
brain. Analysis of microglia samples suggested that microglia
have lower ratios than whole brain tissues (∼1) and therefore
do not contribute to the high X-expression in brain. In short,
the strong association of ChrX reduction with the neuronal ref-
erence genes and the ancillary results on laser extracted neurons
and microglia cells suggest that this pattern of reduced expression
reflects the changes in cell populations that occur in neurodegen-
erative disorders. These results have been reproduced consistently
in multiple datasets, diseases and across different array platforms,
sampling protocols, and normalization methods. Chromosome
specificity was striking and the pattern of expression extended
through the whole of ChrX with the exception of the far p-
end. The simplest explanation for these results is that the high
X:autosome ratio in brain (Nguyen and Disteche, 2006b) is caused
by high X-expression in neurons. These presumably show higher
expression of the genes located in the Chromowave expression
pattern than other cell types or tissues. As neurons die off this
causes the average expression of these genes to reduce, creat-
ing the observed pattern and implying a shift in the X:autosome
ratio. Alternatively it could be that microglia show abnormally low
X:autosome ratios, however this is less likely as the X:Autosome
ratio for these cells is∼1, which is the expected ratio for non-brain
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tissue. That microglia show lower ratios than whole tissue is
explained by noting that whole tissue contains neurons and so
show higher ratios than tissues which do not contain neurons.
Interestingly, the pattern obtained by Chromowave from
ChrX resembles the pattern reported in ChrX-inactivation. X-
inactivation is an epigenetic event in mammalian females that
results in the transcriptional silencing of one X-chromosome. In
X-inactivation not all X-linked genes are repressed and, in humans,
the proportion of genes on the X-chromosome that escapes inac-
tivation is more than 15%, mostly located on the p-end (Brown
and Greally, 2003). One can therefore speculate on a link between
epigenetic mechanisms of X-inactivation and the increased acti-
vation of X-linked genes in neurons and also on the reasons for
this higher activity. As well as brain genes, the X-chromosome
also has a large number of genes related to the immune system.
X-chromosome dosage has been linked to autoimmune disorders
(Libert et al., 2010; Svyryd et al., 2012) while immune reactivity
and neuroinflammation have long been associated with neuro-
logical conditions (Fang et al., 2012; Medeiros et al., 2012; Saing
et al., 2012). This makes it tempting to speculate on possible rea-
sons for the high X-expression in neurons and possible links with
disease progression, however much further work would be needed
to investigate such possibilities. In any case however, the results
contained in this manuscript suggest that, studies on the role of
X-linked probes in neurodegenerative disorders must be tightly
controlled for cell numbers.
One further point of note in this report is the consistent obser-
vation that when female subjects were removed the X-pattern was
significantly different between controls and PD subjects. In our
view, this does not mean that females show significantly differ-
ent X-loadings to males, or differ in their response to neuronal
loss. Possibly males show a larger distinction between controls
and PD patients due to female subjects having a more benign phe-
notype with milder degeneration (Haaxma et al., 2007). In this
case, further studies with greater sample sizes are warranted.
Samples used in this investigation came from a range of dis-
eases, though more were taken from PD than other neurological
conditions. Since results were similar in all datasets, PD and
non-PD, it is unlikely that this has added any meaningful bias
to the analysis. Additionally although there are clear similarities
between the profiles obtained from these different conditions the
analysis does not rule out disease specific changes occurring on
ChrX and in the autosomes. However any disease specific results
are outside the scope of this paper and no autosomal pattern was
replicated in the datasets.
It is worth noting thatChromowave results are made up of many
hundreds of probes. Individually these probes have only weak
(mostly non-significant) associations with the neuronal density
and so standard single genes approaches are unlikely to replicate
these findings. Taking the average of many probes does repro-
duce the association, however it does not provide the pattern
Chromowave provided, and is not data driven, requiring a hypoth-
esis about chromosome wide expression changes. This helps to
demonstrate the usefulness of the Chromowave approach when
applied to situations involving spatially adjacent genes.
In conclusion, we observed a spatial pattern of low ChrX
expression associated with a range of neurological diseases. This
pattern was strongly associated with the activity of a set of
autosomal “neuronal reporter” genes. This result most likely
reflects high X-expression in neurons, a view supported by
the higher X:autosome ratio found in micro-dissected tissue.
This likely relates to the previously known high X-expression
in brain tissues which this suggests it occurs largely in neu-
rons. The spatial pattern of the X-expression more interest-
ingly suggests a link between X dosage compensation, ChrX
up-regulation in brain and the development and function of
neuronal cells. Assuming the findings and interpretations here
can be confirmed, it is also to our knowledge the first time
that a specific cell type has been linked to spatially coherent
transcription.
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